The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Analysis of the lung microbiome in the “healthy” smoker and in COPD.
Open accessAbstract
Although culture-independent techniques have shown that the lungs are not sterile, little is known about the lung microbiome in chronic obstructive pulmonary disease (COPD). We used pyrosequencing of 16S amplicons to analyze the lung microbiome in two ways: first, using bronchoalveolar lavage (BAL) to sample the distal bronchi and air-spaces; and second, by examining multiple discrete tissue sites in the lungs of six subjects removed at the time of transplantation. We performed BAL on three never-smokers (NS) with normal spirometry, seven smokers with normal spirometry ("healthy smokers", HS), and four subjects with COPD (CS). Bacterial 16 s sequences were found in all subjects, without significant quantitative differences between groups. Both taxonomy-based and taxonomy-independent approaches disclosed heterogeneity in the bacterial communities between HS subjects that was similar to that seen in healthy NS and two mild COPD patients. The moderate and severe COPD patients had very limited community diversity, which was also noted in 28% of the healthy subjects. Both approaches revealed extensive membership overlap between the bacterial communities of the three study groups. No genera were common within a group but unique across groups. Our data suggests the existence of a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas. Most strikingly, there were significant micro-anatomic differences in bacterial communities within the same lung of subjects with advanced COPD. These studies are further demonstration of the pulmonary microbiome and highlight global and micro-anatomic changes in these bacterial communities in severe COPD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under certain conditions, Streptococcus gordonii can attack host fibronectin, and subsequent cytokine production can induce inflammatory responses (Erb-Downward et al., 2011; Liu et al., 2018).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Erb-Downward et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O’Hara, R. B., Sólymos, P., Stevens, M. H. H., Szöcs, E., et al. (2001) · doi:10.32614/cran.package.vegan · Cited by 27,099
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
An Ordination of the Upland Forest Communities of Southern Wisconsin
Bray, J. R., & Curtis, J. T. (1957) · Ecological Monographs · doi:10.2307/1942268 · Cited by 11,736
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Spirometric Reference Values from a Sample of the General U.S. Population
Hankinson, J., Odencrantz, J. R., & Fedan, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,220
Topographical and Temporal Diversity of the Human Skin Microbiome
Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C., Program, N. C. S., Bouffard, G. G., Blakesley, R. W., Murray, P. R., et al. (2009) · Science · doi:10.1126/science.1171700 · Cited by 2,953
Research works printed but not linked: 1
- C Fletcher, 1978, Community Health., J Epidemiol, 32, 282
Cited by
Sorted by citations
Items 501–600 of 970
Twenty years of changes in the definition of early chronic obstructive pulmonary disease
Chen, D., Curtis, J. L., & Chen, Y. (2023) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2023.03.004 · Cited by 23
“In addition to alterations in the genome and transcriptome, a previous study has also identified changes in the microbiome of the small airways in COPD patients, which deserves further in-depth investigation.”
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
O’Shaughnessy, M., Sheils, O. M., & Baird, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512296 · Cited by 22
“They identified a core COPD lung microbiome that included Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas [80].”
BackgroundSignature Motifs Identify an Acinetobacter Cif Virulence Factor with Epoxide Hydrolase Activity
Bahl, C. D., Hvorecny, K. L., Bridges, A. A., Ballok, A. E., Bomberger, J. M., Cady, K. C., O’Toole, G. A., & Madden, D. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518092 · Cited by 20
Planning and Analyzing a Low-Biomass Microbiome Study: A Data Analysis Perspective
Austin, G. I., & Korem, T. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae378 · Cited by 22
Inhalation exposure to chemicals, microbiota dysbiosis and adverse effects on humans
Utembe, W., & Kamng’ona, A. W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176938 · Cited by 21
Duvallet, C., Larson, K., Snapper, S. B., Iosim, S., Lee, A., Freer, K., May, K. E., Alm, E. J., & Rosen, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216453 · Cited by 19
“However, there is little consensus on whether there exists a distinct or ”core” 52 lung microbiome that is consistent across people [9, 11, 12, 13].”
BackgroundResultThe respiratory microbiome after lung transplantation: Reflection or driver of respiratory disease?
Eskind, C. C., Shilts, M. H., Shaver, C. M., Das, S. R., & Satyanarayana, G. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16568 · Cited by 20
Tan, L., Zhong, M., Liu, Q., Chen, Y., Zhao, Y., Zhao, J., Dusenge, M. A., Yao, F., Ye, Q., Hu, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1193340 · Cited by 19
“Under certain conditions, Streptococcus gordonii can attack host fibronectin, and subsequent cytokine production can induce inflammatory responses (Erb-Downward et al., 2011; Lu et al., 2017).”
BackgroundDoes “all disease begin in the gut”? The gut-organ cross talk in the microbiome
Chaudhary, P. P., Kaur, M., & Myles, I. A. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13180-9 · Cited by 26
“Dysbiosis in the lung microbiome has been associated with respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (Erb-Downward et al. 2011; Dickson et al. 2013; Garcia-Nunez et al. 2014; Campbell et al. 2023).”
BackgroundYang, K., Wang, S. L., Ding, Z., Zhang, K., Zhu, W., Wang, H., Pan, M., Li, X., Wang, H., & Yu, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1397989 · Cited by 22
Macrophages and the microbiome in chronic obstructive pulmonary disease
Sandhu, K. K., Scott, A., Tatler, A. L., Belchamber, K. B. R., & Cox, M. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0053-2024 · Cited by 23
“[73], the main taxa reported in the lungs of patients with COPD include Pseudomonas , Veillonella , Prevotella , Fusobacterium , Haemophilus and Streptococcus species.”
Cefazolin shifts the kidney microbiota to promote a lithogenic environment
Agudelo, J., Chen, X., Mukherjee, S., Nguyen, J., Bruggeman, L. A., & Miller, A. W. (2024) · Nature Communications · doi:10.1038/s41467-024-54432-6 · Cited by 19
“1g), a taxon that is resident in other organs, such as lung tissue 24 .”
THE HUMAN MICROBIOTA: THE ROLE OF MICROBIAL COMMUNITIES IN HEALTH AND DISEASE
Botero, L. E., Delgado-Serrano, L., Hernández, M. L. C., Portillo, P. D., & Eder, M. M. Z. (2015) · Acta Biológica Colombiana · doi:10.15446/abc.v21n1.49761 · Cited by 19
“…analysis, recent culture-independent studies have shown that healthy lungs are colonized by diverse bacteria (Hilty et al., 2010; Charlson et al., 2011; Erb-Downward et al., 2011; Huang et al., 2011; Segal and Blaser, 2014), and that many of these come from the oral cavity (Bassis et al., 2015).”
BackgroundProfiling of lung microbiota in the patients with obstructive sleep apnea
Lu, D., Yao, X., Abulimiti, A., Cai, L., Zhou, L., Hong, J., & Li, N. (2018) · Medicine · doi:10.1097/md.0000000000011175 · Cited by 19
The lung microbiome and transplantation
Mitchell, A. B. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000631 · Cited by 19
When human cells meet bacteria: precision medicine for cancers using the microbiota.
Zhang, H., & Sun, L. (2018) · Europe PMC (PubMed Central) · Cited by 20
Lung microbiome in healthy and diseased individuals
Evsyutina, Y., Komkova, I., Zolnikova, O., Tkachenko, P., & Ivashkin, V. T. (2017) · World Journal of Respirology · doi:10.5320/wjr.v7.i2.39 · Cited by 19
The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
Hussell, T., Lui, S., Jagger, C. P., Morgan, D. J., & Brand, O. J. (2018) · European Respiratory Review · doi:10.1183/16000617.0032-2018 · Cited by 22
Immune Dysregulation in Chronic Obstructive Pulmonary Disease
Pang, X., & Liu, X. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2334296 · Cited by 20
“…to the severity of COPD, and the reduction in airway microbial diversity in COPD patients is associated with acute COPD exacerbations, emphysema severity, bronchial remodelling and T lymphocyte infiltration (Bereswill et al., 2011; Dicker et al., 2021; Garcia-Nuñez et al., 2014; Sze et al., 2015).”
BackgroundChauhan, N. S., Monika, Kumar, T., Sharma, P., & Goyal, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817193-6.00005-4 · Cited by 19
Alsayed, A. R., Abed, A. I., Jarrar, Y. B., Alshammari, F., Alshammari, B., Basheti, I. A., & Zihlif, M. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062118 · Cited by 17
“Despite the inadequate nature of the literature surrounding the microbiome of the lower airways for ACO patients, studies have confirmed that many of the bacteria present in COPD patients are those that are present in the healthy population [9,10,38,39].”
BackgroundResultInfluentialCrosstalk between the lung microbiome and lung cancer
Meng, Y., Mao, Y., Tang, Z., Qiu, X., Bajinka, O., Tan, Y., & Song, Z. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106062 · Cited by 19
Wang, J.-Z., Yuan, D., Yang, X., Sun, C.-H., Hou, L., Zhang, Y., & Gao, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1291980 · Cited by 18
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
Ntolios, P., Tzilas, V., Bouros, E., Avdoula, E., Karakasiliοtis, I., Bouros, D. E., & Steiropoulos, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040442 · Cited by 20
Huebinger, R. M., Liu, M., Dowd, S. E., Rivera-Chávez, F. A., Boynton, J., Carey, C., Hawkins, K. S., Minshall, C. T., Wolf, S. E., Minei, J. P., et al. (2013) · Surgical Infections · doi:10.1089/sur.2012.095 · Cited by 18
“Studies of the microbiome relative to asthma [14] and chronic obstructive pulmonary disease [14] as compared with those in healthy controls demonstrated that the respiratory tract is in fact not sterile.”
BackgroundChappell, K. J. (2013) · Journal of Medical Microbiology & Diagnosis · doi:10.4172/2161-0703.s1-005 · Cited by 19
“Several studies have used culture-independent techniques to characterize the microbiota of the respiratory tract, in various states of health and disease including chronic lung diseases, such as Cystic Fibrosis [24-26] and Chronic Obstructive Pulmonary Disease [27-29] as well as acute respiratory infections [30-32].”
BackgroundLower airway microbiota in COPD and healthy controls
Tangedal, S., Nielsen, R., Aanerud, M., Drengenes, C., Husebø, G. R., Lehmann, S., Knudsen, K. S., Hiemstra, P. S., & Eagan, T. (2024) · Thorax · doi:10.1136/thorax-2023-220455 · Cited by 19
Dissimilarity of Airway and Lung Tissue Microbiota in Smokers Undergoing Surgery for Lung Cancer
Reinhold, L., Möllering, A., Wallis, S., Palade, E., Schäfer, K., Drömann, D., Rupp, J., Graspeuntner, S., & Dalhoff, K. (2020) · Microorganisms · doi:10.3390/microorganisms8060794 · Cited by 17
“Our data are not comparable to studies using explants from patients with endstage lung diseases [4,15,17] or swabs from resected tissue [16], which probably reflects differences in patient populations and methodology.”
ResultCrosstalk between Body Microbiota and the Regulation of Immunity
Rojas, C., Gálvez‐Jirón, F., Solminihac, J. D., Padilla, C., Cárcamo, I., Villalón, N., Kurte, M., & Pino‐Lagos, K. (2022) · Journal of Immunology Research · doi:10.1155/2022/6274265 · Cited by 17
Cai, L., Gao, P., Wang, Z., Dai, C., Ye, N., İlkit, M., Xue, X., Xiao, J., & Chen, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988708 · Cited by 17
“Different parts of the lungs of the same individual have different microbiomes (70).”
BackgroundMicrobial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection
Lane, S., Hilliam, Y., & Bomberger, J. M. (2022) · Journal of Bacteriology · doi:10.1128/jb.00295-22 · Cited by 18
Drakopanagiotakis, F., Stavropoulou, E., Tsigalou, C., Nena, E., & Steiropoulos, P. (2022) · Biomedicines · doi:10.3390/biomedicines10123195 · Cited by 18
The airway mycobiome and interactions with immunity in health and chronic lung disease
Katsoulis, O., Pitts, O., & Singanayagam, A. (2024) · Oxford Open Immunology · doi:10.1093/oxfimm/iqae009 · Cited by 19
Mechanisms coupling the mTOR pathway to chronic obstructive pulmonary disease (COPD) pathogenesis
Goyal, A., Chopra, V., Garg, K., & Sharma, S. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.12.005 · Cited by 17
Increased Myeloid Cell Production and Lung Bacterial Clearance in Mice Exposed to Cigarette Smoke
Basilico, P., Cremona, T. P., Oevermann, A., Piersigilli, A., & Benarafa, C. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0017oc · Cited by 17
New microbiota found in sputum from patients with community-acquired pneumonia
Chen, C., Shen, T. H., Tian, F., Lin, P., Li, Q., Cui, Z., Zhang, Y., Xue, M., Ye, J., Guo, X., et al. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt116 · Cited by 18
“The method based on massive parallel pyrosequencing of bacterial 16s rDNA amplicons of V3 regions is a common method in microecology, and its feasibilities have been proven in other infections [11–15].”
MethodChang, C. H., Zhu, H., Shen, N., Chen, Y., He, B., Zhao, J., & Yao, W.-Z. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.898043 · Cited by 17
Beyond Hygiene: Commensal Microbiota and Allergic Diseases
Hong, S., Kim, K. S., & Surh, C. D. (2017) · Immune Network · doi:10.4110/in.2017.17.1.48 · Cited by 17
“In the lung, which is often mistakenly considered as a sterile site, Bacteriodetes, Firmicutes and Proteobacteria phyla are identified as the major phyla (40-42).”
BackgroundRole of the Airway Microbiome in Respiratory Infections and Asthma in Children
Dinwiddie, D. L., Denson, J. L., & Kennedy, J. L. (2018) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2018.0958 · Cited by 18
Pérez‐Cobas, A. E., Ginévra, C., Rusniok, C., Jarraud, S., & Buchrieser, C. (2020) · mBio · doi:10.1128/mbio.00889-20 · Cited by 20
Hilty, M., Wüthrich, T. M., Godel, A., Adelfio, R., Aebi, S., Burgener, S. S., Illgen-Wilcke, B., & Benarafa, C. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000485 · Cited by 18
“Analyses of bronchoalveolar lavage have shown smokinginduced differences in the mouth and oropharynx, but not in the lower respiratory tract microbiome of healthy human subjects [13, 25].”
BackgroundThe human microbiota: a new direction in the investigation of thoracic diseases.
Hui, A. W. H., Lau, H.-W., Chan, T. H.-T., & Tsui, S. K. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.07.41 · Cited by 18
“In contrast to an earlier study (19), a more recent and larger study comparing the lung microbiome in moderate and severe COPD patients with normal subjects yielded contradictory results that there is a higher level of microbial diversity in the lung and this discrepancy may be explained by age differences (18).”
ResultXu, Y., Zhang, Y., & Cardell, L. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0409oc · Cited by 17
Loss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD
Sze, M. A., Utokaparch, S., Elliott, W. M., Hogg, J. C., & Hegele, R. G. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006677 · Cited by 17
Characterization of throat microbial flora in smokers with or without COPD
Diao, W., Shen, N., Du, Y., Qian, K., & He, B. (2017) · International Journal of COPD · doi:10.2147/copd.s140243 · Cited by 17
“5,6 9 However, microbiome studies of throat samples are limited.”
InfluentialLipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts
Yatskov, I. A., Beloglazov, V. A., & Ряпова, Э. И. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-laa-2229 · Cited by 18
The association between the respiratory tract microbiome and clinical outcomes in patients with COPD
Yu, S., Zhang, H., Wan, L., Xue, M. F., Zhang, Y., & Gao, X. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127244 · Cited by 18
The neonate respiratory microbiome
Pirr, S. M., Willers, M., & Viemann, D. (2025) · Acta Physiologica · doi:10.1111/apha.14266 · Cited by 16
The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma
Lu, J., Xiong, L., Zhang, X., Liu, Z., Wang, S., Zhang, C., Zheng, J., Wang, G., Zheng, R., Simpson, J. L., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/3890601 · Cited by 17
“Interestingly, in patients with COPD, a similar discrepancy where increased or decreased diversity of lower airway microbiota is reported [12, 54].”
Short term dynamics of the sputum microbiome among COPD patients
Sinha, R., Weissenburger-Moser, L. A., Clarke, J., Smith, L. M., Heires, A. J., Romberger, D. J., & LeVan, T. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191499 · Cited by 17
Caro, J. C. L., Santibáñez, M., Rivero, J. L. G., Villanueva, M. Á., Sainz, J., GonzálezAstorqui, P., Hierro, M., Porres, M. R., Parás‐Bravo, P., Mira, Á., et al. (2019) · Respiration · doi:10.1159/000501988 · Cited by 16
IL-17A in Human Respiratory Diseases: Innate or Adaptive Immunity? Clinical Implications
Bullens, D. M. A., Decraene, A., Seys, S., & Dupont, L. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/840315 · Cited by 16
“Although more study is warranted, at least, the results of the cited study provide a framework for characterizing the role of two important pathogens, Pseudomonas andHaemophilus, in the development, progression, and/or exacerbation of COPD [40].”
BackgroundResultMilani, C., Alessandri, G., Mangifesta, M., Mancabelli, L., Lugli, G. A., Fontana, F., Longhi, G., Anzalone, R., Viappiani, A., Duranti, S., et al. (2020) · mSystems · doi:10.1128/msystems.00404-20 · Cited by 15
Microbial Airway Colonization: A Cause of Asthma and Pneumonia?
Ege, M. J., & von Mutius, E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1680ed · Cited by 16
“Within the Lung HIV Microbiome Project (7) and other investigations (3, 8), a pulmonary core microbiome of healthy individuals has been proposed.”
BackgroundGastrointestinal consequences of lipopolysaccharide-induced lung inflammation
McQuade, R. M., Bandara, M., Diwakarla, S., Sahakian, L., Han, M. N., Thaalibi, M. A., Natale, M. R. D., Tan, M., Harwood, K. H., Schneider‐Futschik, E. K., et al. (2022) · Inflammation Research · doi:10.1007/s00011-022-01657-0 · Cited by 15
Characterization of the Lower Airways and Oral Microbiota in Healthy Young Persons in the Community
Filho, F. S. L., Peters, C. M., Sheel, A. W., Yang, J., Nislow, C., Lam, S. C., Leung, J. M., & Sin, D. D. (2023) · Biomedicines · doi:10.3390/biomedicines11030841 · Cited by 15
“[39], it is possible that the bacterial microbiota may be influenced by regional differences in lungs within the same individual (e.”
BackgroundWei, L., Zhang, L., Zhang, Y., Yan, L., Liu, B., Cao, Z., Zhao, N., He, X., Li, L., & Lu, C. C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116381 · Cited by 14
Lineros, R., Fernández-Delgado, L., Vega, A. P., Chacón, P., Doukkali, B., Monteseirı́n, J., & Perez, D. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051243 · Cited by 18
Maetani, T., Tanabe, N., Sato, A., Shiraishi, Y., Sakamoto, R., Ogawa, E., Sakai, H., Matsumoto, H., Satô, S., Date, H., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00235-2023 · Cited by 15
“Although pre-COPD may share similar pathophysiological changes to COPD [38], COPD is characterised by more severe airway remodelling/destruction [39, 40], higher frequency of exacerbation and more complex alteration of microbiome [41, 42].”
BackgroundKou, Z., Liu, K., Qiao, Z., Wang, Y., Li, Y., Li, Y., Yu, X., & Han, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1407439 · Cited by 19
Mohamed, S. A. (2019) · Journal of Nursing Education and Practice · doi:10.5430/jnep.v9n6p41 · Cited by 21
“These finding in the line with Erb-Downward and coworkers[36] analyzed of the lung microbiome in the “Healthy” smoker on COPD among 14 patients, they found 8/14(57.”
ResultMulti-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
Lee, A. J., Einarsson, G. G., Gilpin, D. F., & Tunney, M. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.569821 · Cited by 14
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung
Woods, D. F., Flynn, S., Caparros-Martin, J. A., Stick, S. M., Reen, F. J., & O’Gara, F. (2021) · Antibiotics · doi:10.3390/antibiotics10070766 · Cited by 16
“In contrast, the lower airways in respiratory disease consists of bacterial communities with shallow diversity and high abundance [4,5,57,61,72,86,87].”
BackgroundCross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma
Ramakrishna, L., de Vries, V. C., & de Lafaille, M. A. C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8296-4 · Cited by 15
Challenges in understanding lung microbiome: It is NOT like the gut microbiome
Chang, D., Cruz, C. S. D., & Sharma, L. (2019) · Respirology · doi:10.1111/resp.13759 · Cited by 16
The Microbiota in Respiratory Disease
Erb‐Downward, J. R., Huffnagle, G. B., & Martínez, F. J. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0567ed · Cited by 15
“1073–1080) follows those by Hilty and colleagues (2), Erb-Downward and colleagues (3), Huang and colleagues (4), and Charlson and colleagues (5) and continues to expand our nascent understanding of the composition of the pulmonary microbiome.”
BackgroundThe lung microbiome in HIV-positive patients with active pulmonary tuberculosis
Ueckermann, V., Lebre, P. H., Geldenhuys, J., Hoosien, E., Cowan, D. A., van Rensburg, L. J., & Ehlers, M. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-12970-3 · Cited by 16
Lower respiratory tract microbiome composition and community interactions in smokers
Campos, M., Cickovski, T., Fernandez, M., Jaric, M., Wanner, A., Holt, G. E., Donna, E., Mendes, E. S., Silva‐Herzog, E., Schneper, L. M., et al. (2023) · Access Microbiology · doi:10.1099/acmi.0.000497.v3 · Cited by 15
“N o d e s a r e c o l o u r e d b y c l u s t e r s . of oropharyngeal species [16, 19].”
BackgroundInfluentialSu, K., Gao, Y., & He, J. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-231 · Cited by 16
Thermostable Subunit Vaccines for Pulmonary Delivery: How Close Are We?
Foged, C. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160202141603 · Cited by 14
Chen, T., Pei, Y., Zhang, L., & Zhang, Y. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.136300 · Cited by 14
Malayil, L., Chattopadhyay, S., Kulkarni, P., Hittle, L. E., Clark, P. I., Mongodin, E. F., & Sapkota, A. R. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10681-1 · Cited by 15
Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice
Galaris, A., Fanidis, D., Stylianaki, E.-A., Harokopos, V., Kalantzi, A.-S., Moulos, P., Dimas, A. S., Hatzis, P., & Aidinis, V. (2022) · Biomedicines · doi:10.3390/biomedicines10020494 · Cited by 15
“These phyla are also reported to be the most prevalent in the human adult lung [43,44].”
BackgroundParticipation in research bronchoscopy: a literature review
Martinsen, E. M. H., Leiten, E. O., Bakke, P. S., Eagan, T., & Grønseth, R. (2016) · European Clinical Respiratory Journal · doi:10.3402/ecrj.v3.29511 · Cited by 14
“Previous studies on the airway microbiota in asthma and COPD patients with bronchoscopic sampling had low numbers of participants (2, 5, 6).”
BackgroundMooney, D., Edgar, D., Einarsson, G. G., Downey, D. G., Elborn, J. S., & Tunney, M. M. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1268568 · Cited by 14
Precision medicine in chronic obstructive pulmonary disease
Halpin, D. M. G. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002042 · Cited by 14
Bălan, A. M., Bodolea, C., Trancă, S., & Hagău, N. (2023) · Healthcare · doi:10.3390/healthcare11091345 · Cited by 14
Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease
Stankovic, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041403 · Cited by 15
“Furthermore, although cigarette smoking is the main cause of COPD, and smoke is rich in highly toxic compounds, reported results have indicated that it does not seem to affect lung bacteriobiota composition [13,22].”
InfluentialKoceva, H., Amiratashani, M., Akbarimoghaddam, P., Hoffmann, B., Zhurgenbayeva, G., Gresnigt, M. S., Marcelino, V. R., Eggeling, C., Figge, M. T., Amorim, M. J., et al. (2025) · Open Biology · doi:10.1098/rsob.240231 · Cited by 15
Ong, E., Sun, P., Berke, K., Zheng, J., Wu, G., & He, Y. O. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3194-6 · Cited by 13
“For example, the fields of cancer prognosis and prediction [35], stem cell differentiation and aging [36], lung disease [37] all face the challenge.”
BackgroundOriano, M., Zorzetto, L., Guagliano, G., Bertoglio, F., van Uden, S., Visai, L., & Petrini, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.539319 · Cited by 13
“Healthy lungs microbiota composition is dynamic and among the multiple bacteria present in the lungs, whose abundance and composition vary in time, bacteroidetes and firmicutes constitute a retained core (Erb-Downward et al., 2011; Morris et al., 2013; Segal et al., 2013).”
BackgroundKnudsen, K. S., Lehmann, S., Nielsen, R., Tangedal, S., Haaland, I., Hiemstra, P. S., & Eagan, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262082 · Cited by 13
Metabolomics of Respiratory Diseases
Moitra, S., Bandyopadhyay, A., & Lacy, P. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_614 · Cited by 15
Environmental Arsenic Exposure and Microbiota in Induced Sputum
White, A., Watts, G. S., Lu, Z. J., Meza‐Montenegro, M. M., Lutz, E., Harber, P. I., & Burgess, J. L. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110202299 · Cited by 13
“Recent culture-independent techniques demonstrate that diverse microbial communities reside in the human respiratory tract [10,11] and their composition or characterization may be altered by disease status [11–15],”
BackgroundCope, E. K., Goldberg, A. N., Pletcher, S. D., & Lynch, S. V. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21819 · Cited by 13
Common Lung Microbiome Identified among Mechanically Ventilated Surgical Patients
Smith, A. D., Zhang, Y., Barber, R. C., Minshall, C. T., Huebinger, R. M., & Allen, M. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166313 · Cited by 14
Cigarette smoke prevents M1 polarization of alveolar macrophages by suppressing NLRP3
Feng, H., & Zheng, R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121854 · Cited by 12
Cheng, Z.-X., & Zhang, J. (2024) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2023.0442 · Cited by 15
Throat microbiota drives alterations in pulmonary alveolar microbiota in patients with septic ARDS
Li, N.-N., Kang, K., Zhou, Y., Liu, Y., Zhang, Q., Luo, P.-Y., Wang, L., Man, M., Lv, J.-F., Wang, X., et al. (2024) · Virulence · doi:10.1080/21505594.2024.2350775 · Cited by 12
“Subjects with decreased lung function exhibit lower diversity in lung microbiota compared to healthy individuals [10].”
BackgroundHuo, C., Jia, Q., Jiao, X., Jiang, Q., Zeng, X., Zhang, J., Wang, Y., Zhu, Z., & Tian, L. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.138238 · Cited by 12
Ran, Z., Liu, J., Wang, F., Xin, C., Shen, X., Zeng, S., Song, Z., & Xiong, B. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.103.16 · Cited by 12
Zdziarski, P., Paściak, M., & Gamian, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.636180 · Cited by 12
“Although the changes in the microbiome in asthmatic and COPD patients are well described, the effects of ICS have not been evaluated (Charlson et al., 2011; Erb-Downward et al., 2011; Ghebre et al., 2018).”
BackgroundHuman airway and lung microbiome at the crossroad of health and disease (Review)
Raudoniūtė, J., Bironaitė, D., Bagdonas, E., Kulvinskienė, I., Jonaitytė, B., Danila, E., & Aldonytė, R. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11718 · Cited by 13
“In lung explants, many separate, distinct, and individual microbial communities were mapped (27).”
BackgroundVariance Component Selection With Applications to Microbiome Taxonomic Data
Zhai, J., Kim, J., Knox, K. S., Twigg, H. L., Zhou, H., & Zhou, J. J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00509 · Cited by 11
“Studies of the respiratory tract microbiome did not start until the discovery of microbiome in the lungs of both healthy (Erb-Downward et al., 2011; Morris et al., 2013; Twigg III et al., 2013) and diseased populations (Zemanick et al., 2011; Lozupone et al., 2013) using culture-independent…”
BackgroundUpper respiratory tract mycobiome alterations in different kinds of pulmonary disease
Xu, X., Ding, F., Hu, X., Yang, F., Zhang, T., Dong, J., Xue, Y. W., Liu, T., Wang, J., & Jin, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1117779 · Cited by 12
“The respiratory tracts of healthy individuals have shown that they are not sterile as formerly thought but are composed of a complex microbial community termed the microbiome (Erb-Downward et al., 2011).”
BackgroundMorales‐González, F., Lira-Lucio, J. A., Falfán‐Valencia, R., Márquez-García, J. E., Abarca‐Rojano, E., Ramírez‐Venegas, A., Sansores, R. H., García‐Gómez, L., Hernández‐Pérez, A., & Pérez-Rubio, G. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.825 · Cited by 9
The contribution of respiratory microbiome analysis to a treatable traits model of care
Taylor, S., O’Farrell, H. E., Simpson, J. L., Yang, I. A., & Rogers, G. B. (2018) · Respirology · doi:10.1111/resp.13411 · Cited by 11
Emerging cellular and molecular interactions between the lung microbiota and lung diseases
Li, X., & Meng, X. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1992345 · Cited by 11
“One consistent observation in the field is that both healthy and diseased lungs harbour a microbiota (Hilty et al. 2010; Charlson et al. 2011; Erb-Downward et al. 2011), and the microorganisms in healthy lungs are unique from the lung microorganisms in lung diseases, such as respiratory infections…”
BackgroundInfluentialCharacteristics of asthmatics with detectable IL-32γ in induced sputum
Kwon, J., Chang, H. S., Heo, J.-S., Bae, D.-J., Lee, J.-U., Jung, C. A., Son, J.-H., Park, J., Kim, S. H., Min, K., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.06.005 · Cited by 11
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis
O’Neill, K., Einarsson, G. G., Rowan, S., McIlreavey, L., Lee, A. J., Lawson, J., Lynch, T. B., Horsley, A. R., Bradley, J. M., Elborn, J. S., et al. (2019) · Respirology · doi:10.1111/resp.13653 · Cited by 11
Metadata
- Authors
- Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., Martinez, F. J., & Huffnagle, G. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Huffnagle, Gary B.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-22
- Volume
- 6
- Issue
- 2
- Pages
- e16384
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3043049
- OpenAlex
- W2163401084
- Cited by
- 973
- References
- 42
- Citations by year
- 2026: 32 · 2025: 50 · 2024: 59 · 2023: 66 · 2022: 73 · 2021: 57 · 2020: 74 · 2019: 62 · 2018: 85 · 2017: 80 · 2016: 75 · 2015: 72 · 2014: 68 · 2013: 57 · 2012: 49
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (R01 HL082480)
- University of Michigan (UL1 RR024986)
- National Institutes of Health (n01hr46162-13-0-1)
- Michigan Institute for Clinical and Health Research (UL 1RR024986)
- University of Michigan Comprehensive Cancer Center (P30 CA46952, CA46952)
- National Heart, Lung, and Blood Institute (R01HL082480, N01HR046162, T32HL007749)
- National Cancer Institute (P30 CA 46952)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK070875, RR024986, R01DK070875)
- National Center for Research Resources (UL1RR024986)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- lung microbiome, chronic obstructive pulmonary disease, healthy smokers, bronchoalveolar lavage, lung tissue sampling, bacterial community diversity, core microbiome, Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, Porphyromonas, lung transplantation
- MeSH terms
- Adult, Aged, Bronchoalveolar Lavage Fluid, Bronchoscopy, DNA, Bacterial, Female, Health, Humans, Lung, Male, Middle Aged, RNA, Ribosomal, 16S, Smoking, Sequence Analysis, DNA, Pulmonary Disease, Chronic Obstructive, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review